NOTCH1 and neoplasm: Notwithstanding, genetic alterations that activate neurogenic locus notch homolog protein 1 (NOTCH1) signaling and T-cell transcription factors, coupled with inactivation of the inhibitors of CDK4/alternate reading frame (INK4/ARF) tumor suppressors, are hallmarks of T-ALL [5,7,8].